DR Congo Begins Vaccination of Healthcare Workers Against Ebola

The Democratic Republic of Congo (DRC) has initiated vaccinations against Ebola, prioritizing health workers and other front-line personnel. The vaccine being administered this week is licensed for a different strain, and its effectiveness against the Bundibugyo strain of Ebola has not yet been determined. Currently, there is no approved vaccine or treatment for this new strain, and clinical trials are ongoing to develop a suitable vaccine. The first vaccinations are taking place in the city of Kisangani. According to Congolese Health Minister Samuel Roger Kamba, more than 50,000 doses of the vaccine have been received. The outbreak is primarily located in the Ituri province, which borders Uganda. Kamba stated, "We will cover all the provinces that are around Ituri, moving in the ring towards the centre of the outbreak." The World Health Organization (WHO) announced last week that 70,000 doses of the Ervebo vaccine have been approved for use in the DRC. Of these, about 20,000 doses will be utilized in a clinical trial to assess their effectiveness against the new strain. Health workers have requested additional doses. As of Tuesday, the DRC has reported 5,713 confirmed cases of Ebola, with 2,744 deaths, according to government statistics. This outbreak is the deadliest in the history of Ebola outbreaks in the DRC. The situation is exacerbated by challenging conditions, including insecurity, displacement, a health workers’ strike, and significant population movements. The WHO has indicated that the outbreak remains uncontrolled and is likely to exceed the 2014-2016 West Africa Ebola outbreak, which resulted in over 11,000 fatalities, mainly in Guinea, Liberia, and Sierra Leone.